ArticleBMC cancer2021

Pembrolizumab plus lenvatinib with or without hepatic arterial infusion chemotherapy in selected populations of patients with treatment-naive unresectable hepatocellular carcinoma exhibiting PD-L1 staining: a multicenter retrospective study.

Song Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.